Shanmugam Muthusamy (CIK 1870913) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-02). Recent activity: Buy ANIP (11,116 shares), Sell ANIP (2,898 shares), Sell ANIP (47,012 shares), Sell ANIP (52,988 shares), Sell ANIP (47,010 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-02 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF R&D, COO-NOVITIUM OPS | Buy | 11,116 | $857,599 |
| 2026-02-13 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF R&D, COO-NOVITIUM OPS | Sell | 2,898 | $220,972 |
| 2025-08-22 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF R&D, COO-NOVITIUM OPS | Sell | 47,012 | $4.2M |
| 2025-08-22 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF R&D, COO-NOVITIUM OPS | Sell | 52,988 | $4.8M |
| 2025-08-18 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF R&D, COO-NOVITIUM OPS | Sell | 47,010 | $4.2M |
| 2025-08-18 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF R&D, COO-NOVITIUM OPS | Sell | 52,990 | $4.6M |
| 2025-05-13 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF R&D, COO-NOVITIUM OPS | Sell | 700 | $53,781 |
| 2025-02-18 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF R&D, COO-NOVITIUM OPS | Buy | 14,362 | $0 |
| 2025-02-18 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF R&D, COO-NOVITIUM OPS | Buy | 9,574 | $0 |
Source: SEC Form 4 filings · as of 2026-03-02